Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Accelerating Discovery: Actionable NASH Cirrhosis Endpoints

New clinical study to advance development of treatments for liver cirrhosis

The £30m ADVANCE study is the most extensive study into liver disease worldwide

January 10, 2024 Accelerating Discovery: Actionable NASH Cirrhosis Endpoints, Boehringer Ingelheim, Liver cirrhosis, Newcastle University, News, University of Edinburgh
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy